Chicago-based Northwestern Medicine recorded an operating income of $132.7 million (4.5% operating margin) in the second quarter of 2026, down from $149.6 million (5.7% margin) during the same period last year, according to its April 15 financial report.
Northwestern Medicine reported total operating revenue of $3 billion for the three months ended Feb. 28, up from $2.6 billion during the same period last year. Patient service revenue was $2.7 billion, up from $2.4 billion. Rental and other revenue totaled $245.2 million, up from $195.7 million.
Total operating expenses were $2.8 billion, up from $2.5 billion during the same quarter last year. Salaries and benefits totaled $1.4 billion, up from $1.2 billion. Supply expenses totaled $733.5 million, up from $620.3 million. Purchased services expenses were $252.3 million, up from $236.7 million.
Northwestern Medicine reported a net income of $580.6 million in the second quarter of 2026, up from $220.1 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
